Last reviewed · How we verify

NCT03237806: ARDS

Effects of Sedation on Transpulmonary Pressure and Lung Homogenous

Completed NA Last updated 20 March 2018
What this trial tests

NA trial testing Deep sedated in ARDS in 24 participants. Completed in 18 March 2018.

Timeline
31 May 2015
Primary endpoint
18 January 2018
18 March 2018

Quick facts

Lead sponsorSoutheast University, China
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposescreening
Enrollment24
Start date31 May 2015
Primary completion18 January 2018
Estimated completion18 March 2018
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Southeast University, China

Who can join

Adults 18 to 85, any sex, with ARDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The acute respiratory distress syndrome (ARDS) is characterized by severe respiratory failure. Open Lung and Lung Protective Strategy have been proved to improve mortality of ARDS patients. Preserving spontaneous breathing (SB) is good for inflating the lung lobe near diaphram during mechanical ventilation, however, strong respiratory drive could generate more transpulmonary pressure in ARDS patients, which increase the stress and strain in injured lung. Nonetheless, it's not clear if sedative has any effects on transpulmonary pressure of ARDS patients.The purpose of this study is to investigate the effects of sedation on transpulmonary pressure of ARDS patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for ARDS

Currently open trials in the same condition.

Other Southeast University, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03237806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing